222 related articles for article (PubMed ID: 20021285)
1. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
Wang HM; Liang PH
Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
[TBL] [Abstract][Full Text] [Related]
2. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
Ramajayam R; Tan KP; Liang PH
Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
Wang QM
Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
Wang QM
Prog Drug Res; 2001; Spec No():229-53. PubMed ID: 11548209
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
[TBL] [Abstract][Full Text] [Related]
7. Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells.
Sun D; Chen S; Cheng A; Wang M
Viruses; 2016 Mar; 8(3):82. PubMed ID: 26999188
[TBL] [Abstract][Full Text] [Related]
8. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors.
Ramajayam R; Tan KP; Liu HG; Liang PH
Bioorg Med Chem; 2010 Nov; 18(22):7849-54. PubMed ID: 20947359
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Target Pocket Similarity and Progress into Research on Inhibitors of Picornavirus 3C Proteases.
Wan L; Wang X; Wang T; Yuan X; Liu W; Huang Y; Deng C; Cao S
Chem Biodivers; 2023 Mar; 20(3):e202201100. PubMed ID: 36808685
[TBL] [Abstract][Full Text] [Related]
11. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
[TBL] [Abstract][Full Text] [Related]
12. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
Wanga QM; Chen SH
Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
[TBL] [Abstract][Full Text] [Related]
13. Individual and common inhibitors of coronavirus and picornavirus main proteases.
Kuo CJ; Liu HG; Lo YK; Seong CM; Lee KI; Jung YS; Liang PH
FEBS Lett; 2009 Feb; 583(3):549-55. PubMed ID: 19166843
[TBL] [Abstract][Full Text] [Related]
14. Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C-like protease?
Ng CS; Stobart CC; Luo H
Rev Med Virol; 2021 Sep; 31(5):1-22. PubMed ID: 33624382
[TBL] [Abstract][Full Text] [Related]
15. Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro.
Jung E; Lee JY; Kim HJ; Ryu CK; Lee KI; Kim M; Lee CK; Go YY
Bioorg Med Chem Lett; 2018 Aug; 28(14):2533-2538. PubMed ID: 29866517
[TBL] [Abstract][Full Text] [Related]
16. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of 3C cysteine proteinases from Picornaviridae.
Lall MS; Jain RP; Vederas JC
Curr Top Med Chem; 2004; 4(12):1239-53. PubMed ID: 15320724
[TBL] [Abstract][Full Text] [Related]
18. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS).
St John SE; Tomar S; Stauffer SR; Mesecar AD
Bioorg Med Chem; 2015 Sep; 23(17):6036-48. PubMed ID: 26190463
[TBL] [Abstract][Full Text] [Related]
19. Computational modeling of the bat HKU4 coronavirus 3CL
Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
Kim Y; Mandadapu SR; Groutas WC; Chang KO
Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
